Jubilant Ingrevia Ltd reports stronger financial performance for the first quarter of fiscal year 2027 (quarter ended 30 June 2026), with net profit increasing year on year. The company’s Q1FY27 net profit rises to ₹105.8 crore (₹105.82 crore reported in consolidated results), up about 40.9% from ₹75.1 crore in the year-ago quarter. Revenue also grows, with consolidated revenue from operations reported at ₹1,300.27 crore, up about 25.3% year on year from ₹1,037.87 crore. Total income for the quarter is stated at ₹1,310.49 crore. Profit before tax is reported at ₹140.86 crore, higher than both the preceding quarter (₹111.71 crore in Q4FY26) and the year-ago quarter (₹99.77 crore in Q1FY26). Earnings per share are ₹6.70. The company’s filings also reference segment revenue contributions from Speciality Chemicals (₹637.00 crore), Nutrition & Health Solutions (₹243.82 crore), and Chemical Intermediates (₹525.17 crore), along with exceptional items related to new labour codes for the year ended 31 March 2026.